AstraZeneca EBIT 2010-2024 | AZN

AstraZeneca EBIT for the quarter ending September 30, 2024 was $2.106B, a 7.78% increase year-over-year.

  • AstraZeneca 2023 EBIT was 8.193B, a 118.07% increase from 2022.
  • AstraZeneca 2022 EBIT was 3.757B, a 255.78% increase from 2021.
  • AstraZeneca 2021 EBIT was 1.056B, a 79.54% decline from 2020.

EBIT can be defined as earnings before interest and taxes.

AstraZeneca EBIT 2010-2024 | AZN

  • AstraZeneca 2023 EBIT was 8.193B, a 118.07% increase from 2022.
  • AstraZeneca 2022 EBIT was 3.757B, a 255.78% increase from 2021.
  • AstraZeneca 2021 EBIT was 1.056B, a 79.54% decline from 2020.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B